UK MCA Plans Curbs On Painkillers
The UK Medicines Control Agency has announced plans to review the status and distribution of painkillers, following prolonged debate about paracetamol and overdose.
The MCA proposes that sales of paracetamol in packs containing more than 30 tablets should be available on prescription only, while packs containing up to 30 tablets should be available from pharmacies only. Packs of 12 would continue to be available on general sale.
The Paracetamol Information Centre notes that paracetamol is the most widely-used medicine in the UK, with over 30 million people taking it every year. "We are studying all of the MCA's proposals carefully and will work with them to help reduce the misuse of paracetamol," says a press release from the Centre.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze